Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds BIOC.
No tracked institution reports a position in BIOC as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-05-17 | 1-for-30reverse |
| 2020-09-08 | 1-for-10reverse |
| 2018-07-10 | 1-for-30reverse |
| 2016-09-29 | 1-for-3reverse |
| 2005-02-07 | 1-for-200reverse |
No one on the platform has traded BIOC yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 1 of the last 4 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-03-29 | $-0.22 | $-32.57 | -14702.3% |
| 2022-11-21 | $-4.80 | $-9.91 | -106.5% |
| 2022-11-10 | $-0.16 | $-9.31 | -5718.8% |
| 2022-05-23 | $-7.21 | $-4.80 | +33.4% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BIOCBiocept, Inc. | $0.43 | +0.00% | $450786 | — |
| ATLNAtlantic International Corp. | $0.90 | +0.00% | $73M | — |
| GBSGBS Inc. | $0.47 | -1.58% | $433577 | — |
| LFLYLeafly Holdings, Inc. | $37.00 | +0.00% | $115M | — |
| OTRKOntrak, Inc. | $0.33 | +358.19% | $2M | — |
| PHGEBiomX Inc. | $0.15 | +4.45% | $2M | — |
| PHIOPhio Pharmaceuticals Corp. | $1.09 | +0.93% | $13M | — |
Source: Financial Modeling Prep · peers by sector/industry